고객센터
찾아오시는길

HOME > 학술방 > 줄기세포연구회줄기세포연구회

Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow-up of three patients

소영 | 2019.08.14 17:30 | 조회 909
Abstract 

Aim: Osteoarthritis is a degenerative joint disease characterized by the destruction of joint cartilage. Mesenchymal stem cells (MSCs) are found in low numbers in normal cartilage, mainly in the superficial layer, acting as repairing agents. In OA, MSCs are seen in larger numbers, but act chaotic and are unable to repair the cartilage. The synovial membrane becomes inflamed and interacts with the cartilage. Transplanted MSC have the ability to normalize them, redirecting them to their normal function. In a preliminary study, we showed that MSC could improve knee OA in four patients at 6 months. This report shows their long-term follow-up at 5 years. 
Methods: One patient was lost to follow-up at 2 years and three were followed for 5 years. They were aged 55, 57, 65 and 54 years, and had moderate to severe knee osteoarthritis. The worse knee of each patient was injected with 8–9 9 106 MSC. 
Results: As previously reported, all parameters improved in transplant knees at 6 months (walking time, stair climbing, gelling pain, patella crepitus, flection contracture and the visual analogue score on pain). Then, they started gradually to deteriorate, but at 5 years they were still better than at baseline. PGA (Patient Global Assessment) improved from baseline to 5 years. The better knee at baseline (no MSC), continued its progression toward aggravation and at 5 years became the worse knee. 
Conclusion: Transplant knees were all in a rather advanced stage of OA. Earlier transplantation may give better results in long-term follow-up. This is what future studies have to demonstrate. 
Key words: bone marrow, intra-articular injection, knee osteoarthritis, mesenchymal stem cell, stem cell transplantation, tissue culture.



Reference:

Davatchi, F., Abdollahi, B. S., Mohyeddin, M., & Nikbin, B. (2015). Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow-up of three patients. International Journal of Rheumatic Diseases, 19(3), 219-225. doi:10.1111/1756-185x.12670



첨부파일 확인 부탁드리겠습니다.

감사합니다.
논문검색
번호 제목 글쓴이 조회 날짜
16 결국 유전자 치료의 리스크를 감당하게 될 것 같습니다 이희영 191 2025.01.04
15 적혈구 엑소좀의 중요성 이희영 218 2024.12.11
14 이런논문 필요하죠 Mesenchymal Stem Cell Therapy .. 이희영 267 2024.10.11
13 초음파 설명동영상인데 알아듣기 좋아요 이희영 311 2024.08.22
12 무릎 초음파 참고 자료입니다 이희영 298 2024.08.16
11 참고로 배양육 관련 자료도 보십시요 이희영 293 2024.08.13
10 배양중 일어나는 entosis는 원래 자연 기전입니다. 이희영 262 2024.08.01
9 배양육 영역에서는 근육세포 중에 발견되는 중간엽줄기세포를 섬유지방모세포라.. 이희영 280 2024.08.01
8 배양 중 체세포융합에 의한 DNA 재조합은 안정적이고 암을 억제한다 이희영 285 2024.08.01
7 지방줄기세포의 다양한 사용과 일반적 리뷰 이희영 311 2024.08.01
6 골관절염 줄기세포치료 비교 관리자 470 2024.07.24
5 엑소좀 시대에 무릎에 자가 엑소좀을 어떻게 활용할까요? 무릎치료를 위한 자가 엑소좀 활용 296 2024.07.24
4 무릎치료를 위한 지방 SVF치료와 지방조직 분쇄 치료 [1] 이희영 317 2024.07.21
3 이곳은 "줄기세포 항노화 연구회"로 개칭하기로 했습니다. 이희영 288 2024.07.21
>> Mesenchymal stem cell therapy for knee o.. 소영 910 2019.08.14
1 Stem cell application for osteoarthritis.. 소영 882 2019.08.14